Saxenda
Liraglutide 3.0mg
by Novo Nordisk
The pioneering GLP-1 injectable — FDA-approved for adults and adolescents 12+
8.4 kg
Average weight loss at 56 weeks
SCALE Obesity trial, NEJM 2015
63%
Patients achieving ≥5% weight loss
SCALE Obesity trial, NEJM 2015
33%
Patients achieving ≥10% weight loss
SCALE Obesity trial, NEJM 2015
56 weeks
Primary clinical trial duration
SCALE Obesity trial, NEJM 2015
How It Works
Mechanism of Action
Liraglutide binds to GLP-1 receptors throughout the body, including in the hypothalamus (appetite centre), stomach (slowing emptying), and pancreas (regulating insulin). This multi-site action reduces appetite, increases feelings of fullness, and helps regulate blood sugar levels simultaneously.
Dosage Guide
Always follow your prescribing physician's specific instructions. The schedule below is a general guide.
Starting dose — allows gradual body adjustment
First escalation — appetite suppression begins
Continued dose increase
Near full therapeutic dose
Full maintenance dose — once-daily injection at any time of day
Key Benefits
Side Effects
Common Side Effects
- Nausea (most common, especially early)
- Diarrhoea
- Constipation
- Vomiting
- Injection site reactions
- Low blood sugar (particularly with other diabetes medications)
- Headache
Rare but Serious
- Pancreatitis
- Gallbladder problems
- Increased heart rate
- Kidney problems
- Depression or suicidal thoughts (rare)
Seek immediate medical attention if you experience any serious adverse effects.
Frequently Asked Questions
Who Is This For?
- Adults with BMI ≥30 kg/m²
- Adults with BMI ≥27 kg/m² with comorbidities
- Adolescents aged 12+ weighing ≥60kg with initial BMI at/above 95th percentile
- As an adjunct to diet and exercise
Not Suitable For
- Personal or family history of MTC or MEN 2
- Pregnancy
- Prior serious hypersensitivity to liraglutide
- Patients with severe kidney disease
Starting from
$149.99
Join waitlist to be notified
How It Works
You Might Also Consider
Wegovy
Average 21% body weight loss — the gold standard in medically supervised weight loss
Mounjaro
Up to 22.5% body weight loss — the most effective weight loss medication in clinical history
Nevolat
The affordable liraglutide option — same proven GLP-1 mechanism as Saxenda at a lower cost